Solana

Solana FCF/Debt

The Free Cash Flow to Debt Ratio of Solana (HSDT) as of Oct 16, 2026 is -92,050.00 %. In the previous year, Free Cash Flow to Debt Ratio was -18,324.56 % — a change of 402.33% (lower).

FCF/Debt

-92,050.00 %

YoY

402.33%

Last updated:

Free Cash Flow to Debt Ratio of Solana is 2024 -92,050.00 % . Free Cash Flow to Debt Ratio of Solana was 2023 -18,324.56 % . It decreases by 402.33% lower compared to the previous year.

The Solana FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
-1,934.09 USD
Jan 1, 2018
-145.70 USD
Jan 1, 2019
-3,340.19 USD
Jan 1, 2020
-12,968.13 USD
Jan 1, 2021
-448,066.67 USD
Jan 1, 2022
-13,024.55 USD
Jan 1, 2023
-18,324.56 USD
Jan 1, 2024
-92,050.00 USD
The Solana FCF/Debt history
YEARFCF/DebtYoY
-92,050.00 %+402.33%
-18,324.56 %+40.69%
-13,024.55 %-97.09%
-448,066.67 %+3,355.14%
-12,968.13 %+288.25%
-3,340.19 %+2,192.56%
-145.70 %-92.47%
-1,934.09 %+445.09%
-354.82 %-24.66%
-470.95 %-41.09%
-799.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solana Stock analysis

What does Solana do? Solana Co, with ticker HSDT and ISIN US42328V8761, is a health care company based in Newtown, United States. The company has 21 employees and went public on June 27, 2014. Its website is https://heliusmedical.com/. Solana Co operates within the health care sector, focusing on neurological wellness through non-invasive medical technologies. The company develops, licenses, or acquires non-invasive platform technologies designed to enhance the brain's natural healing capabilities. While the source description mentions a product called the portable neuromodulation stimulator (PoNS) device, which is described as a class II medical device in Canada for treating balance deficits related to mild-to-moderate traumatic brain injury, Solana Co's profile does not confirm this product or its specific applications. The company's operations and product details are not elaborated beyond the provided information. Solana Co is headquartered in Newtown, Pennsylvania, and its primary focus remains on neurological wellness within the health care industry. The company's public listing date and employee count are the only financial and operational details available in the provided data. No additional acquisitions, founding year, or specific product names beyond the general description are confirmed in the factual information provided. Solana is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Solana stock

Free Cash Flow to Debt Ratio of Solana is -92,050.00 % in 2024.

Free Cash Flow to Debt Ratio of Solana changed from -18,324.56 % to -92,050.00 %, representing a 402.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Solana since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Solana with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Solana

All Key Metrics — Solana